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In 1958 Schwartz eta/. first described the suppressive effect on antibody for- 
mation in rabbits of the purine antagonist 5-mercaptopurine (1). Stimulated by 
this  finding  a  number  of investigators  have  studied  the  effect of  different 
antimetabolites on antibody formation (2-4) and on delayed hypersensitivity 
(5, 6) in various animal species. These findings are not only of theoretical inter- 
est,  but have become of practical importance in homotransplantafion  (7-9), 
in the treatment of autoimmune disorders in man (10,  11), and in experimental 
animals (12). 
The action of antimetabolites on the immune response differs from species to 
species. 6-mercaptopurine (6-MP) and aminopterin have both been reported to 
inhibit delayed hypersensitivity in the guinea pig (5, 13). In contrast, antibody 
formation in this animal was only suppressed by aminopterin (13, 14). Thus the 
mechanism of action of these two compounds on the immune response in guinea 
pigs appears to be different. For this reason it seemed of interest to study and 
compare the effect of these two antimetabolites on an experimental immune 
disease in this species. 
In the present study immune thyroiditis was selected as a  suitable experi- 
mental immune disease in the guinea pig, because the responsible antigen is well 
known  and  antibody formation  as  well  as  delayed hypersensitivity against 
thyroglobulin can be easily determined. 
The antimetabolites were administered during the immunization phase  in 
order to study their effect on the immune response as well as on the changes in 
the thyroid gland. In addition, the antimetabolites were given to animals which 
*This work was supported by grants No. AM-3777 and AM-4819, United States Public 
Health Service. 
:~Postdoctoral Fellow of  Graduate  Training  Program 2A-5282, United States  Public 
Health Service. 
§Health Research Council Career Scientist of the City of New York under contract No. 
1-124. 
869 870  EXPERIMENTAL  ~  I"HYROIDITI$ 
had  been  immunized  and  which  had  already  developed  thyroiditis,  since  it 
seemed important  to determine whether the course of an immune disease could 
be altered by these agents. 
Materials and Methods 
Animals.--Female Hartley strain albino guinea pigs weighing 230 to 270 gm were  used 
throughout all experiments. They were maintained on laboratory chow and water ad Ubidum. 
The control animals gained weight, weighing 300 to 350 gm at the end of the experiments. 
Immunization.--Thyroid glands of normal guinea pigs were collected and frozen at --20°C 
to a block of thyroid tissue. This block in the frozen state was cut with a razor blade into fine 
sections. The sections were extracted overnight with 3  times their weight of 0.15  ~t NaC1. 
The extract was centrifuged at 4°C at 3000 m~x~ for 15 minutes. The clear supernatant was 
used as thyroid extract and stored at  --20°C until used. The protein content of the extract 
was determined by the method of Folin-Ciocalteu. The preparations usually contained 20 to 
30 nag protein per ml. Purified thyroglobulin was prepared according to the method of Der- 
rien et a/. (15), modified by Roitt and Doniach (16). 
In the first series of experiments 500/zg of purified thyrogiobulin was used for the immuni- 
zation, while in all the following experiments 750/~g of thyroid extract protein served as 
antigen. The latter was as effective as purified thyroglobulln, but fewer thyroid glands were 
necessary to prepare the antigenic substrate. 
The thyroid extract was diluted with 0.15 ~x NaC1 and emulsified in an equal volume of 
complete  Freund  adjuvant  (Difco Laboratories,  Inc.,  Detroit)  to  a  final concentration of 
750/~g protein thyroid extract per 0.2 ml. 0.1 ml of this mixture was injected in each front 
foot-pad on day 0 and the same amount was injected on day 4 in the hind foot-pads. 
Skin Testing.--The animals were skin-tested with 50/~g guinea pig thyroglobulin in 0.1 ml 
0.15 M NaC1.  The reaction was read 6 and 24 hours later. Infiltration of the skin 24 hours 
after injection of the thyroglobulin measuring 2  X  2 mm or more was classified as a positive 
delayed  reaction. Induration of the skin was taken as indication of  positive  delayed  hy- 
persensitivity since 3  of  20  non-immunized animals showed  small  erythematous  areas  24 
hours after skin  testing with thyroglobulin. The  diameter of erythema in the immunized 
animals was not much larger than that of non-immunized animals. 
Serum Antibodles.--At the end of the experiments, the animals were exsanguinated and 
the blood allowed to clot at room temperature for 2 hours before separation of the serum. 
The sera were heat-inactivated at 56°C for 30 minutes and absorbed with ~.~ volume of packed 
washed sheep erythrocytes at 4°C overnight. 
A  tanned cell hemagglutination test was performed according to  a  modified method of 
Heller et a/. (17). Sheep red cells (Probio Inc., New York) in Alsever's solution were washed 
3 times with phosphate buffer pH 8 described in reference 17. A 50 per cent concentration of 
cells was  treated with an equal volume of tannic acid  diluted  1:20,000 for  10 minutes at 
37°C. The tannic acid  (Mallinckrodt, analytical reagent) was prepared dally in buffer. The 
tanned cells were centrifuged, washed once with buffer, and reconstituted to a  20 per cent 
solution for coating with the antigen. Equal parts of 20 per cent tanned sheep erythrocytes 
and a solution containing 2 mg thyroglobulin per ml buffer were  incubated for 30 minutes at 
37°C  in a  water bath. After coating with the antigen the sheep cells were washed 3  times 
with buffer and reconstituted in buffer containing 0.5 per cent normal guinea pig serum to a 
final concentration of  0.5  per cent  erythrocytes. 2-fold  dilutions were  made in the micro 
titrator of Takatsy  (Danube International Trade  Corp.,  New  York)  starting with a  first 
dilution of 1 : 16, and using 0.05 ml antiserum and 0.05 ml thyroglobulin-coated sheep eryth- 
rocytes. The plates were allowed to stand overnight at room temperature before reading the HANS  L. SPIEGELBERG AND  PETER A. MIESCHER  871 
agglutination titer. Positive and negative control sera were included in each test as well as 
controls with uncoated tanned erythrocytes to exclude a  non-specific  or spontaneous ag- 
glutination. 
The sera were further analyzed for precipitating antibodies in the agar double diffusion 
technique in petri dishes using 0.5 per cent agar in 0.15 M NaCL 
Histolog~a2 ExaminaJion.--Immedlately after  sacrificing  the  animals both lobes of the 
thyroid were removed and fixed in 10 per cent formalin. 3 to 4 sections through the largest 
part of the thyroid were stained with hematoxyLin and eosin. In almost all cases both lobes 
showed  a  similar degree  of thyroiditis; when different degrees  of thyroiditls were  observed 
the stronger reaction was taken as the result. The degree of thyroiditls was graded arbitrarily 
from 1+ to 4+ according to the extent of infiltration  of the cross-section of the thyroid gland: 
Negative, normal thyroid tissue (without or only one small perivascnlar  infitration); 1  +, 2 to 
4 small infiltration  areas; 2+, infiltration  of 25 to 50 per cent; 3+, infiltration  of 50 to 75 per 
cent and 4+, complete infiltration of the thyroid tissue. 
White Blood Counts.---O.025 ml blood was taken from the retroorbital plexus at regular 
intervals with  a  calibrated heparinized glass  pipette  and the  blood was  transferred into 
0.475 ml Turck solution and immediately mixed to obtain a homogeneous suspension. The 
leucocytes were counted and differenciated  into mononuclear and polymorphonuciear cells in 
the Thoma WBC chamber. 
6-Mercaptopurine.---6-MP was kindly supplied by. Dr. G. H. Hitchings, Burroughs, Well- 
come,  and Company, Inc. Tuckahoe, New York. 50 mg of 6-MP per ml of physiological 
saline was dissolved with the minimal amount of 10 per cent NaOH necessary to completely 
dissolve  the drug. All preparations were  made up daily. 6-MP was administered intraperi- 
toneally or intramuscularly in the muscle of the hind legs. The most effective dosage 0f 150 
mg/kg intraperitoneally  caused a mortality of 75 per cent of the animals ff given daffy, how- 
ever 5 injections weekly reduced the toxic effect to about 25 per cent mortality. Since pre- 
liminary experiments had shown that daffy  injections did not result in a better effect than 5 
injections weekly, the latter treatment schedule was used throughout all experiments. Treat- 
ment with 150 mg/kg intraperitoneally resulted in an average weight loss of 20 per cent. 
Aminopterin.--Aminopterin was kindly supplied by Dr. Ruegsegger,  Lederle Laboratories 
Division, American Cyanamid Company, Pearl River,  New York,  as methotrexate vials. 
Aminopterin was given daffy intraperitoneally in dosages of 5 mg and 10 mg/kg which were 
well tolerated  by all animals; they gained weight almost at the same rate as the control 
animals. 
Treatment Schedule.--The time of administration of 6-MP or aminopterin was performed 
according to seven different schedules shown in Table I. 
RESULTS 
Immune Response and I~c~nce of Thyro~itls in Control Animab.--Delayed 
hypersensitivity and antibodies against thyroglobulin as well as the appearance 
of thyroiditis were determined repeatedly in a total of 101 control animals which 
have been immunized with two injections of thyroid extract on days 0 and 4 as 
indicated under Material  and Methods. 
Out of 11 animals skin-tested on day 10, 5 (45 per cent) showed a positive de- 
layed skin reaction. The 11 animals were exsanguinated on day 11 for antibody 
determination and histological examination of the thyroid gland. 4 of these ani- 
mals exhibited serum antibodies in a  titer of 1:16 and higher; 3 animals showed 
mild  thyroidifis. 872  EXPERIMENTAL  IMMUNE  THYROIDITIS 
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52 animals were skin-tested on day 20 and bled on day 21. The incidence of 
delayed hypersensitivity was 65.5 per cent and the incidence of antibodies 92 
per cent. Thyroiditis was present in 82 per cent of the animals. 
20  animals  were  examined 30  days  after immunization.  18  (90 per  cent) 
showed a  positive delayed skin  reaction;  18  animals  had  serum  antibodies. 
Thyroiditis was found in 16 (80 per cent) animals. 
18 animals were skin-tested at day 40 and bled on day 41. 12 animals (66.6 
per cent) showed a positive delayed skin reaction and 2 animals showed an im- 
mediate reaction of the Arthus type. All 18 animals had severe thyroiditis. 
The average and standard deviations of serum antibody titer, diameter of 
skin infiltration, and degree of thyroiditis of the different control groups are 
TABLE I 
Treatmen~ Schedules 
Schedule 
~o. 
I 
II 
III 
IV 
V 
VI 
VII 
-10 to-1 
o 
+ 
o 
o 
o 
o 
o 
Days of treatment with antimetabolites* 
0 to9 
+ 
o 
+ 
+ 
o 
o 
o 
10 to 19 
+ 
o 
o 
o 
+ 
o 
o 
20 to 29 
0 
+ 
+ 
30 to 39 
+ 
Day of 
Day of  termination 
skin test  of 
experiment 
20  21 
20  21 
20  21 
30  31 
20  21 
30  31 
40  41 
+,  administration  of antimetaboUtes;  0,  no administration  of antimetabolites. 
* Days 0 and 4,  days of injection of antigen in all treatment schedules. 
graphically registered, together with the data of the corresponding treated an- 
imals, in Text-figs. 1 to 10. 
The development of immune thyroiditis in the control animals is character- 
ized by a change in the thyroid epithelium cells and by a round cell infiltration 
The epithelium cells of the normal guinea pig thyroid appear flat in cross-section 
(Fig. 1). These epithelium cells become swollen in animals developing thyroiditis 
and appear cuboidal (Fig. 2.). Simultaneously, inflammatory mononuclear cells 
appear in the perivascular spaces, mainly histiocytes and lymphocytes, extend- 
ing gradually until the whole thyroid gland becomes infiltrated (Fig. 2). The 
graduation of the severity of thyroiditis has been based on the extent of infil- 
tration with round cells as outlined under Material and Methods. 
Immune Response and Inc~ence of Thyroiditis in Animals Treated with 6-MP. 
--A total of 204 guinea pigs were treated with 6-MP. All seven schedules of 
drug administration  (Table I) were used. 
Treatment according to schedule I: The effect of 6-MP on antibody formation 
according to schedule I for different dosages and route of administration is sum- 874  EXPERIMENTAL  IMMUNE  EOIDITI$ 
marized in Text-fig.  1.  No  significant suppression  of antibody formation to 
thyroglobulin was found by all dosages used. In two out of three experiments 
with the highest dosage of 150 mg/kg intraperitoneally the average antibody 
titer was found slightly higher than in the control animals immunized simul- 
taneously. A  similar result was  obtained with the  agar diffusion technique, 
where 61 per cent of the control animals showed precipitating antibodies com- 
pared with 55 per cent (75 mg/kg intraperitoneally) and 45 per cent (150 mg/kg 
intraperitoneally) of the treated animals. 
Delayed hypersensitivity was not significantly  influenced by 75 mg/kg 6-MP 
given intraperitoneally, but markedly depressed by the same dosage given intra- 
muscularly. (Text-fig. 2). 150 mg/kg 6-MP given intraperitoneally was equally 
effective as 75 mg/kg given intramuscularly; only 33 per cent of these animals 
showed a positive skin test in contrast to 65 per cent in the control animals. 
Thyroidifis was  depressed  by all  dosages  used;  animals treated  with  the 
highest dosage (150 mg/kg) developed thyroidifis in only 29.5 per cent in con- 
trast to 82 per cent in the control animals (Text-fig. 2).  No significant  difference 
in the effectiveness in suppression of thyroiditis was found between the intra- 
muscular and intraperitoneal administration of 6-MP. 
The histological pattern of the thyroid of the 6-MP treated animals which 
developed thyroiditis was qualitatively similar to that of control animals al- 
though the intensity of inflammation was usually lower. 
Among control animals exhibiting a  positive skin test 80 per cent showed 
thyroiditis. In the guinea pigs treated with 150 mg/kg 6-MP this coincidence 
was found in 50 per cent of the animals. 
One group of 11 animals was treated with only 3 weekly intraperitoneal in- 
jections of 6-MP (150 mg/kg). This treatment resulted in an equal suppression 
of thyroiditis (3 of 11 animals showed mild thyroiditis), however, no influence 
was observed on the skin test. 
Among the various doses and routes  of administration,  150  mg/kg given 
intraperitoneally was found most active. For this reason, 6-MP was given in this 
dose intraperitoneally to all animals in the subsequent studies. 
Treatment  with 6-MP preceding immunization: Pretreatment with 6-MP of 
11 animals preceding immunization with thyroid extract according to schedule 
II resulted in no significant change of the immune response and development of 
thryoiditis (73 per cent antibodies, 63.5 per cent positive skin test,  73 per cent 
thyroiditis). 
Treatment in the early phase of immunization: Treatment during the first 10 
days of the immunization course (schedule III) was equally effective in depress- 
ing thyroiditis as 6-MP given during the entire period of immunization, however 
delayed hypersensitivity was less depressed; again no influence on antibody 
formation was observed (Text-fig. 3).  11 such treated animals were examined 
20 days after discontinuing of 6-MP treatment (schedule IV) on day 3t: The 
incidence of thyroidltis was not different from that of control animals examined HANS  L.  SPIEGELBEI~G  AND  PETER  A.  MIESCHER  875 
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at day 31. However the severity of thyroiditis was less strong; it was comparable 
to the severity of thyroiditis of control animals 21 days after immunization. 
Treatment witk 6-MP after development of an immune response:--The  effect 
of 6-MP treatment which was initiated only 10 days after immunization accord- 
ing to schedule V resulted in a  similar suppression of thryoiditis as in animals 
treated during the entire course of immunization. Delayed hypersensitivity was 
only mildly suppressed by this treatment (Text-fig. 4). 
Treatment with 6-MP after development of thyroiditis.--The  treatment so far 
described can be called prophylactic, since it was initiated before the develop- 
ment of thyroiditis. In the next series of experiments treatment was started 
after the onset of thyroidltis in order to evaluate its curative effect on immune 
thyroiditis. 
Late treatment beginning at day 20 according to schedule VI resulted in def- 
inite depression of delayed hypersensitivity (Text-fig. 5): Only 31 per cent of 
the 6-MP-treated animals showed a positive delayed skin reaction in contrast to 
90 per cent of the control animals. The examination of the thyroid gland of the 
majority of such treated animals showed marked changes in the histological 
pattern of immune thyroidifis. The perivascular spaces still appeared enlarged, 
but the round cell infiltration had disappeared (Fig. 3). The changes in the epi- 
thelial cells were still visible,  although to a lesser degree in most animals. 
The evaluation of thyroiditis in these animals was done according to the de- 
gree of inflammation. 6 out of 14 animals have shown no more signs of inflamma- 
tion and had an almost normal appearance of the epithelial cells (Fig. 4) and 2 
animals  showed enlarged perivascular spaces beside swelling of the epithelial 
cells. These 8 animals were classified as negative. 3 animals exhibited consider- 
able swelling of the epithelial cells as seen in Fig. 3 and scattered foci of peri- 
vascular round cell infiltrations. These animals were classified as still having 
mild thyroiditis. 3 animals showed no influence on the pattern of thyroiditis. 
The effect of longer treatment with 6-MP initiated at day 20 according to 
schedule VII is summarized in Text-fig. 6.  Delayed hypersensitivity was def- 
initely depressed by this treatment, only 33 per cent of the animals  showed a 
positive skin test. None of the 6-MP treated animals showed an immediate skin 
reaction of the Arthus type in contrast to 2 out of 18 control animals. In con- 
trast to an 100 per cent incidence of severe thyroiditis in the control animals, 
only 4 treated guinea pigs had a comparable degree of thyroidifis. In 12 out of 
the 20 treated animals, a marked diminution of round cell infiltration was ob- 
served, however they still showed swelling of the epithelium and some scattered 
foci of infiltration (result recorded weak positive). 4 animals had an entirely 
negative appearance of the thyroid gland. 
Effect of 6-MP using large amounts of antigen for immunization.---One  group 
of 10 animals was immunized with 10-fold the usual amount of antigen. This 
immunization resulted in a weaker appearance of the immune response than in 
the animals immunized with the small amount of thyroid extract (Text-fig. 7). 878  EXPERIMENTAL  IAUNE  THYROIDITIS 
I-- 
¢3 
o 
I- 
p 
,,o,~ 
'7" 
W 
I--~rl 
o  ~ 
+  + 
e,,I 
O.  _  ,~ 
J 
o  ~  .~ 
a 
E  .~ 
O.  _  "~ 
~8 
j  i  i  i  i  .~ 
Z 
,,  0 
,,  .J 
o  "~ 
z 
+!  I1~ 
Z  W 
ul  X 
-I  o~ 
Z  ~0 
0  ~t 
U 
= 
~f  !° 
~  i 3  ~  ~ 
o  <  ,.  ~ 
~'~ HANS  L.  SPIEGELBERG  AND  PETER  A. MIESCHER  879 
I.- 
I- 
>- 
I- 
'"  Z 
-r 
w 
W  Z 
+  +  + 
I  I  I 
E 
7  I  J  I  . 
I  I  I  I"  I  I 
U'~ 
.J 
Z 
O 
d 
Z 
.J 
0 
0 
Z 
h~ 
0 
Q. 
u 
o  ~ 
u  -  "~ 
°~ 
z  ~ 
o  ~ 
0  >,  ,.~x 
o  ~  .~ 
o  ~ 
z°~z  i.~ 880  EXP]~R~NTAL  TMITUNE  THYEOIDITIS 
I-- 
0 
0 
I,,- 
>. 
I--- 
I-- 
0 
Z 
~,~o  o 
o  ,~ 
o 
'  ~.  0  .~ 
oO  -- 
e~ 
ro  t~  -- 
~.~  .~ 
~  ~  ~  -- 
m 
0  "" 
--t  ,u 
0  -- 
I  I  I  I  I  I  ,~ 
L  .m~ 
Z  Z  ~ 
w  ~  0  Q. 
'.  o  ~:o 
o  ,c  "~  g8 
w  z  o  J  ~ 
~'~"  o,c  ~o  ~  Z  I,u  o.  i, 
"'x  oO  ~.~ HANS  L. SPIEGELBERG  AND  PETER A. MIESCHER  881 
Treatment with 6-MP (150 mg/kg), according to schedule I, of 11 animals 
immunized with this large quantitity of thyroid extract showed a positive skin 
reaction in the same proportion as in the control animals. However none of these 
animals developed thyroiditis. (Text-fig. 7). 
Immune  Response  and  Incidence  of  Thyroiditis  in  Animals  Treated  with 
Aminopterin.--Treatment  schedules I,  III to  V  were used in  a  total of 67 
guinea pigs. 
Treatment according to schedule/.--The effect of aminopterin given in a dose 
of 5 mg/kg intraperitoneally, according to schedule I, is shown in Text-fig. 8. 
This treatment lead to a marked depression of antibody formation; only 2 out 
of 28 animals showed demonstrable serum antibodies. The incidence of delayed 
hypersensitivity and thyroiditis was also significantly depressed, although not 
as strikingly as the serum antibody formation. 
No qualitative changes in the histological pattern of thyroiditis were found. 
The  2  animals which showed serum antibodies did not exhibit  thyroiditis. 
Among the  treated animals with a  positive skin test 40 per  cent exhibited 
thyroiditis. 
Treatment  in the early  phase  of immunization.--The  effect of aminopterin 
(5 mg/kg) administered for the first 10 days according to schedule III is shown 
in Text-fig. 9. Antibody formation was markedly depressed by this treatment, 
however to a lesser extent than in animals treated during the entire period of the 
experiment. Delayed hypersensitivity was only mildly influenced. Thyroiditis 
was equally well suppressed as with the treatment during the whole course of 
immunization. 
Treatment udtk aminopterin after devdopment  of an immune response.--Late 
treatment  in  the  second  period  of  immunization  (5  mg/kg),  according  to 
schedule V, did not influence immune response and thyroiditis (Text-fig. 10). 
However when the double dose of aminopterin was given (10 mg/kg), according 
to schedule V, immune response as well as thyroiditis were depressed (Text-fig. 
10). 
Effect  of 6-MP and Aminopterin on the Number of Circulating  Leucoytes.-- 
Examination  of  the  leucocytes  at  different  time  intervals  resulted  in  the 
following findings. A rise of the number of polymorphonuclear leucocytes was 
found in the  control animals from 3460/mm  8 at day 0 to  9100/ram  3 day 20 
(average  values of 40  animals).  The  number of mononuclear ceils  however 
stayed  constant  during  the  entire  period  (average  values  of  40  animals 
3050/ram  3 at day 0 and 3250/mm  a at day 21). 
The  number of polymorphonuclear leucocytes was strongly depressed  by 
6-MP treatment. No increase as seen in the control animals occurred in the 
animals treated with 150 mg/kg 6-MP  (average values of 21 animals at day 
10,  2600/mm  3 and at day 20,  1620/mm3.)  However after discontinuation of 882  EXPERIMENTAL  ~  TH~ROIDITIS 
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treatment (schedule III) the number of leucocytes increased rapidly, and no 
more depression of the polymorphonuclear  leucocytes  was found at the end of the 
experiment. The number of mononuclear cells was not significantly depressed 
by 6-MP treatment (average values of 21 animals: 3200/ram  8 at day 0 and 2950/ 
mm  8 at day 21). 
Treatment  with  aminopterin  resulted  in  similar  findings,  however  the 
depression of the number of polymorphonuclear leucocytes was not as marked 
as with 6-MP (average value of 29 animals: 2900/ram  s at day 0 and 5500/ram  3 
at day 21). Again no influence on the number of mononuclear cells was observed. 
No  correlation was found in a  total of 50  animals treated with 6-MP  or 
aminopterinbetween the number of polymorphonuclear  leucocytes, mononuclear 
cells, and degree of thyroiditis. 
DISCUSSION 
The  reported  experiments  have  demonstrated  that  two  different  anti- 
metabo]kes,  the  antipurine  antagonist  6-mercaptopurine,  and  the  antifolic 
acid antagonist aminopterin, suppress the development of immune thyroiditis 
in guinea pigs.  Both compounds depress in a  sire/liar manner delayed hyper- 
sensitivity to thyroglobulin in these animals, whereas serum antibody formation 
is only suppressed by aminopterin. 
The results will be discussed from two different points of view: First, the 
pharmacological suppression of immune thyroiditis serves as  a  tool  for  the 
investigation of the pathogenesis of this disease. Second, the mechanism by 
which these compounds suppress immune thyroiditis will he analyzed. 
The  pathogenesis  of  experimental  immune  thyroiditis  is  still  unknown. 
Although a number of facts strongly suggest delayed hypersensitivity to be of 
major  importance  (18-21)  some data  also indicated  serum  antibodies  as  a 
possible trigger factor (22). 
The fact that the two antimetabolites have a  different effect on antibody 
formation is important in the evaluation of immune thyroidifis. If antibodies 
would determine the onset of thyroiditis, aminopterin should have suppressed 
thyroidifis to a much greater extent than 6-MP which was ineffective on anti- 
body formation. However,  the suppressive  action on  thyroiditis of the  two 
compounds was very simillar, and the experimental disease occurred in amino- 
pterin-treated  animals in  which  antibody formation was  not demonstrable. 
These data strongly speak against a  major participation of circulating anti- 
bodies in the pathogenesis of this disease. 
There was a close relationship between animals showing a positive skin test 
and  thyroiditis  confirming  previous  observations  (18,  19).  Under  certain 
conditions the antimetabolites suppressed thyroiditis without influencing the 
result of the skin test. In animals treated only during the first 10 days, this 
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as in the onset of thyroiditis. Thus, these animals would be comparable to non- 
treated  animals  at  day  10,  where  delayed  hypersensitivity  but  not  yet 
thyroiditis is  found. Indeed,  the animals treated  for  10  days later  develop 
thyroiditis. In other experiments the different effect on delayed type of hyper- 
sensitivity and immune thyroiditis may have another reason  relevant to the 
question of the mode of action by which thyroiditis is suppressed. 
It has been proposed that prevention of experimental immune disorders by 
antimetabolites is mediated by the suppression of immune response  (12).  In 
this connection we will confine our discussion only to delayed type of immune 
response since the participation of serum antibodies detected in this study could 
be eliminated as a trigger mechanism of immune thyroiditis. 
In a  number of experimental conditions, thyroiditis was depressed without 
influencing similiarly delayed hypersensitivity, which seem to contradict the 
above mentioned assumption.  Thus  only a  very mild suppressive  effect on 
delayed hypersensitivity was observed in the animals treated from day 10 to 
day 20 of the experiment, while thyroiditis was markedly depressed by this 
procedure. Furthermore the effect on immune response and thyroiditis did not 
show the same dependence of the route of administration. While 6-MP given 
intramuscularly has  a  stronger  effect on the  suppression of delayed hyper- 
sensitivity than intraperitoneal administration, no difference was found with 
respect to the effect on thyroiditis. Finally, higher doses of 6-MP were necessary 
to depress delayed hypersensitivity than thyroiditis. 
These data must be taken into account in the evaluation of the mechanism 
by which these antimetabolites suppress  thyroiditis. Two possible modes of 
action may be considered, not involving the mediation of the suppression of the 
immune response: (a) Suppression of inflammatory cells.  (b) The anti-inflam- 
matory vascular action (independent of antimitotic activity). 
Immune thyroiditis involves almost exclusively mononuclear inflammatory 
cells.  In animals exhibiting thyroiditis, these cells disappear rather promptly 
upon 6-MP treatment. If this disappearance would be the result of the anti- 
mitotic  action,  a  generalized  diminution  of  these  cell  elements  should  be 
observed. However, the mononuclear cells in the peripheral circulation were not 
significantly  reduced by this treatment. The only cell type which was suppressed 
was the polymorphonuclear  leucocyte, which seems not to participate inimmune 
thyroiditis. 
Page el a/. first suggested an anti-inflammatory activity of 6-MP (23). This 
action would especially affect the invasion of mononuclear cells into a locus of 
inflammation. These findings are based on the egg white-skin reaction, which 
may not be an ideal test for investigating non-specific inflammation and which 
may be closely related to immune phenomena. The anti-inflammatory effect 
observed with 6-MP in the egg white test lasted only 48 hours after discontinua- 
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In this connection it is worth noting that the inflammation at the site of the 
injection of Freund adjuvant was not influenced by the anti-metabolite treat- 
ment, macroscopically as well as microscopically (24).  Furthermore, the most 
potent anti-inflammatory compounds such as hydrocorfisone (15 mg/kg/day), 
dexamethasone  (15  mg/kg/day),  prednisolone  (15  mg/kg/day),  and  phen- 
ylbutazone  (100  mg/kg/day)  did  not  influence  delayed  hypersensitivity, 
antibody formation as well as thyroiditis (24). 
The ineffectiveness of anti-inflammatory compounds on immune thyroiditis 
in guinea pigs and the short duration of the anti-inflammatory effect of 6-MP 
in the egg white test speaks against the possibility that thyroidifis is inhibited 
on such a basis. It is obvious that such short lasting anti-inflammatory  activity 
would not prevent immune thyroiditis if the treatment is confined to the first 
10  days of immunization, in  which period  there  is  no inflammation in  the 
thyroid gland. 
The reported experiments do not allow a final conclusion on the mechanism 
of suppression of the immune thyroiditis by 6-MP and aminopterin. Although 
there is no complete relation between the effect on the immune response and 
thyroiditis, it seems probable that the action on thyroiditis is related to  the 
action on the changes of the immune response. 
The fact that 6-MP is still effective on thyroiditis once it has  developed 
may be of practical importance for the use of this drug in human patients. 
Whereas one purpose for its clinical application is the suppression of immune 
response in homotransplantation, another purpose is the treatment of a disease 
in which immune phenomena play a  major role. Our results support  such a 
possibility for the treatment of diseases, such as immune hemolytic anemias and 
systemic lupus erythematosus. 
SUMMARY 
The influence of 6-mercaptopurine and aminopterin was studied on immune 
response and immune thyroiditis  in guinea pigs immunized with thyroid extract. 
1.  Both compounds depressed delayed hypersensitivity to thyroglobulin and 
immune thyroiditis. 
2.  Antibody  formation  to  thyroglobulin  was  strongly  depressed  by 
aminopterin but not significantly influenced by 6-mercaptopurine. 
3.  Immune  response  and  thyroiditis  were  suppressed  as  long  as  the 
compounds were  administered;  after  discontinuation of treatment,  immune 
response and thyroiditis appeared in the same time intervals as observed in 
control animals after initiation of immunization. 
4.  Treatment  with  6-mercaptopurine  and  aminopterin  10  days  after 
immunization lead to suppression of delayed hypersensitivity and thyroiditis. 
5.  Treatment with 6-mercaptopurine of animals after onset of thyroiditis 
lead to suppression of delayed hypersensitivity and disappearance or diminution 
of round cell infiltration in the thyroid. HANS  L. SPIEGELBERG AND  PETER A. MIESCHER  889 
6.  The results are  discussed in  terms of the pathogenesis of experimental 
immune thyroiditis, the mode of action of these antimetabolites on this experi- 
mental immune disease, and in view of the potential value of these compounds 
in human diseases. 
The authors wish to acknowledge the valuable technical assistance of Miss Marthe Fau- 
connet and Miss Cecile Zuber. 
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EXPLANATION OF PLATES 
PLATE 81 
FIG. 1. Structure of the normal guinea pig thyroid gland. Note the flattened shape 
of the epithelial  cells in the cross section, and the blood vessel in the center with a 
small perivascular space.  X500. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 118  PLATE  81 
Spiegelberg and Miescher: Experimental immune thyroiditis) PLATE 82 
FIG. 2. Immune thyroiditis in guinea pigs. The epithelial cells are swollen and appear 
cuboidal. The perivascular spaces  are infiltrated with histiocytes and lymphocytes. 
Note compressed  blood vessel in center.  × 500. TIIE ~OURNAL OF EXPERIMENTAL ~EDICINE VOL. 118  PLATE  82 
(Spiegelberg and Miescher: Experimental immune thyroiditis) PLATE 83 
Fla.  3.  Thyroid gland  in animals  treated  with  6-MP  after  development of thy- 
roiditis (schedules ¥I and VII). The perivascular spaces are still enlarged but free of 
inflammatory cells. Note enlarged perivascular space and light swelling of endothelial 
cells of blood cells.  X500. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 118  PLATE  83 
(Spiegelberg  and Miescher: Experimental immune thyroiditis) PLATE 84 
FIG. 4.  Appearance of the  thyroid gland in animals  treated with 6-MP after de- 
velopment of thyroiditis  (treatment  schedule  VI and  VII)  with  only mild  swollen 
thyroid cells and absence of perivascular round cell infiltration.  ×500. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 118  PLATE  84 
(Spiegelberg and Miescher: Experimental immune thyroiditis) 